Utilization of Real-World Data and the Need for Translation in the Pharmaceutical Sector

Jul 5, 2024
SumaLatam

The utilization of real-world data (RWD) and real-world evidence (RWE) is transforming the pharmaceutical sector, becoming increasingly crucial for drug approval and treatment evaluation. These data provide valuable insights into the effectiveness and safety of treatments under normal usage conditions, which is essential for understanding how medications work in everyday clinical practice.

RWD is collected from various sources, such as electronic medical records, insurance claims, patient surveys, and observational studies. These data allow pharmaceutical companies, researchers, and healthcare professionals to make informed decisions based on real-world evidence, rather than relying solely on controlled clinical trials.

However, for real-world data to be useful on a global scale, it is essential that they are accurately translated and localized. The translation of medical and technical terms must be precise to maintain the integrity of the information and ensure that the results are correctly understood by healthcare professionals in different countries. Additionally, localization adapts the information culturally to make it relevant and understandable in various regional contexts.

At SumaLAtam, we understand the importance of precision and cultural sensitivity in translating medical data. Our team of specialized translators works diligently to ensure that RWD and RWE are accessible and comprehensible to a global audience. We collaborate closely with medical and scientific experts to ensure that each technical term is accurately translated and that the information is culturally relevant.

Our translation and localization services enable pharmaceutical companies and research organizations to fully leverage real-world data. By accurately translating and adapting these data, we facilitate their use in drug approval, treatment evaluation, and healthcare policy formulation. This, in turn, contributes to improved health outcomes worldwide, allowing healthcare professionals to make informed clinical decisions based on robust evidence.

The translation and localization of real-world data are essential for their correct interpretation and application in the pharmaceutical sector. At SumaLatam, we are committed to providing high-quality translations that support these global efforts and enhance healthcare and health outcomes worldwide. Our work ensures that vital information is available and understandable for everyone, regardless of language or location, contributing to a more effective and equitable pharmaceutical sector.

Generative AI and Human Knowledge

Generative AI and Human Knowledge

The combination of generative artificial intelligence (AI) and human knowledge is rapidly changing the landscape of translation in the healthcare sector. This fusion promises to transform the way translation professionals manage medical documents, enhancing both speed...

The Importance of ISO Certifications

The Importance of ISO Certifications

In the field of medical translation, accuracy and precision are critical. One of the ways to ensure high-quality translations is through ISO certifications. These certifications act as a benchmark for translation service providers, guaranteeing that they meet specific...

How COVID-19 Transformed the Medical Translation Landscape

How COVID-19 Transformed the Medical Translation Landscape

The COVID-19 pandemic had a significant impact on various industries, and medical translation is no exception. The urgent need for accurate and timely translations of health-related documents grew exponentially during the pandemic. As the world focused on controlling...

HIPAA Compliance and Its Impact on Healthcare Translation

HIPAA Compliance and Its Impact on Healthcare Translation

In the U.S. healthcare sector, HIPAA compliance is crucial to ensure the privacy and security of patient information. Translation in this field must adhere to strict guidelines to comply with regulations and avoid penalties. Adapting translation processes to HIPAA...